About
Cyfuse Biomedical K.K. is a Japanese startup specializing in regenerative medicine and drug discovery. They have developed a proprietary "Bio 3D Printing" technology that creates three-dimensional tissues and organs solely from cells, without the need for artificial scaffolds. Their technology, which utilizes a "Kenzan method" of stacking cell spheroids, is applied to their Bio 3D printers (Regenova® and S-PIKE®) and the development of regenerative medical products for tissue and organ repair, as well as drug discovery screening tools.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Cyfuse Biomedical K.K. do?
Cyfuse Biomedical K.K. is a Japanese startup specializing in regenerative medicine and drug discovery. They have developed a proprietary "Bio 3D Printing" technology that creates three-dimensional tissues and organs solely from cells, without the need for artificial scaffolds. Their technology, which utilizes a "Kenzan method" of stacking cell spheroids, is applied to their Bio 3D printers (Regenova® and S-PIKE®) and the development of regenerative medical products for tissue and organ repair, a…
How much funding has Cyfuse Biomedical K.K. raised?
Cyfuse Biomedical K.K. has raised a total of $540M in funding. The most recent round on record is Series A.
Where is Cyfuse Biomedical K.K. headquartered?
Cyfuse Biomedical K.K. is headquartered in Osaka, Japan.
When was Cyfuse Biomedical K.K. founded?
Cyfuse Biomedical K.K. was founded in 2010.